Navigation Links
Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development
Date:6/17/2009

Nearly 200 Quantitative Immunoassays for Discovery and Validation of New Biomarker Panels

AUSTIN, Texas, June 17 /PRNewswire/ -- Rules-Based Medicine, Incorporated (RBM), the world's leading multiplexed biomarker testing laboratory, today announced the availability of the most comprehensive collection of quantitative immunoassays for use in advancing safety, efficacy and efficiency in drug and diagnostic development. The new service, DiscoveryMAP(TM) v 1.0, offers customers dynamic coverage of most physiologically relevant pathways, providing biological information and leads for further study. This unique and comprehensive offering increases the odds of identifying new protein biomarker patterns in almost any drug development or diagnostic discovery project.

"Despite the known benefits of biomarkers in drug development, many biomarker discovery efforts fail to contribute because the patterns do not reproduce on a clinically validated platform. The RBM approach is to discover new biomarker patterns on the same platform that will be used in clinical trials," said Craig Benson, RBM chief executive officer. "DiscoveryMAP(TM) was designed in collaboration with our pharmaceutical and biotech customers and includes biomarkers known to be important in the major disease indications for drug development. Once a pattern is discovered, we can seamlessly convert those biomarkers into a new custom panel for high-throughput sample processing."

DiscoveryMAP(TM) v 1.0 utilizes RBM's proprietary multi-analyte profiling (MAP) platform to quantify key blood-based biomarkers representing dozens of important biological pathways.

DiscoveryMAP(TM) provides customers with the most robust, quantitative data compared to any available proteomic service or platform technology. All samples are processed in RBM's CLIA-certified lab using proprietary reagents and software to give the most accurate and reproducible p
'/>"/>

SOURCE Rules-Based Medicine, Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
2. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
3. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
4. Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
5. EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
6. Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities
7. Drug Information Association Launches New 45th Annual Meeting Online
8. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
9. Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair
10. Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
11. Bioniche Pharma Launches Enlon(R) and Enlon-Plus(R) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 Dendreon Corporation (Nasdaq: DNDN ... public offering of 15,000,000 shares of its common stock ... share. Dendreon also granted to the underwriters a ... shares of common stock to cover overallotments, if any. ... 15, 2009, subject to customary closing conditions. ,, J. ...
(Date:12/10/2009)... a division of the National Institutes of Health (NIH), awarded ... its development of a non-invasive, passive diffusion-based treatment for severe, ... ... Salt Lake City, UT (PRWEB) December 10, 2009 -- The ... of Health (NIH), awarded a $2.18 million grant to Aciont ...
(Date:12/10/2009)... YM BioSciences Inc. (NYSE Amex: YMI ; ... that identifies and advances a diverse portfolio of ... today provided an update on the proposed transaction ... Ltd. into YM, details of which were announced ... of Cytopia has unanimously recommended that its shareholders ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... FORD, Pa., Jan. 28 Endo Pharmaceuticals Inc. (Nasdaq: ... and 2008 full-year financial results on February 27, 2009 ... at 10:30 a.m. ET that day to discuss these ... Officer, Nancy J. Wysenski, Chief Operating Officer and Blaine ...
... Today the Swiss,pharmaceutical group Helsinn announced the ... with headquarters in,Bridgewater, New Jersey, for an undisclosed ... of a US-based R&D and commercial operation represents,attainment ... goals. "We are,thrilled at this very important opportunity ...
... NOVATO, Calif., Jan. 28 BioMarin Pharmaceutical,Inc. (Nasdaq: ... BioMarin, will host a conference call and webcast on,Wednesday, February ... quarter,and full year 2008 financial results. , , ... International Dial-in Number: 617.213.8835, Participant ...
Other Biology Technology:Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 3BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET) 2
(Date:12/14/2009)... researchers from the Astrobiology Centre (INTA-CSIC) has shown that ... the formation of the most basic biological molecules can ... to carry out this study, published in the journal ... chemical conditions of the early Earth. , "We have ... solutions it produces hydrogen cyanide, a substance that could ...
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
(Date:12/13/2009)... variants that are associated with the health of the ... 96 scientists from 63 centres in Europe and Australia ... diseases. , The new findings provide hope for better ... (COPD) and asthma. In the past it has been ... that affect the health of the lung are not ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 1iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 3
... A rat thought extinct for 11 million years and a ... discovered in the Greater Mekong Region of Southeast Asia in ... World Wildlife Fund (WWF). , First Contact in ... newly identified by science between 1997 and 2007 which ...
... 15, 2008) A newly published genome sequence of ... rearranged genetic blueprint involving breaks and fusions of genes ... Baylor College of Medicine in a report that appears ... "It,s like a computer program that has become buggy ...
... study uncovers 11 gene variants associated with three ... low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) and ... nutrigenomics researchers looking for links between diet and ... disease risk. , "Practically all genes related to ...
Other Biology News:Over 1,000 species discovered in the Greater Mekong in past decade 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3New gene variants present opportunities in nutrigenomics 2
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
Complexin-1/2 (FL-134)...
RAW; Collected from 8-12 week old sexually mature mice that are free of common parasites; RAW Collected from 8-12 week old sexually mature mice that are free of common parasites....
Biology Products: